About this trial
This study aims to evaluate the effect of the OPUCARE system, a structured mobile health application used before oocyte pick-up (OPU), on medication adherence and quality of life in infertile women. The study will also examine the possible effect of the intervention on state anxiety.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive routine clinical care plus the OPUCARE system. The control group will receive routine clinical care and standard written and verbal information provided by the clinic, without mobile health application support.
The intervention period will last approximately 2 weeks, from the start of medication treatment until oocyte pick-up. Medication adherence, quality of life, and state anxiety will be assessed before and after the intervention period.
Eligibility criteria
Qualifiers
Female participants aged 18 years and older
Diagnosed with primary infertility
Scheduled to undergo oocyte pick-up (OPU) for the first time
Newly starting medication treatment during the period before OPU
Disqualifiers
Diagnosis of secondary infertility
Presence of a serious chronic disease that may significantly affect medication adherence and/or quality of life
Presence of an active serious psychiatric disorder
Cognitive or physical limitation that prevents use of the mobile application
Trial design
Treatments tested in this trial
- OPUCARE
- Routine clinical care